• 研究課題をさがす
  • 研究者をさがす
  • KAKENの使い方
  1. 課題ページに戻る

2020 年度 実施状況報告書

Analysis on detrimental interplay between pathogenic helper T cells, inflammatory antigen-presenting cells and disease-associated microglia in chronic pathogenesis of multiple sclerosis

研究課題

研究課題/領域番号 20K16294
研究機関東京医科歯科大学

研究代表者

張 晨陽  東京医科歯科大学, 大学院医歯学総合研究科, 助教 (40768363)

研究期間 (年度) 2020-04-01 – 2022-03-31
キーワードneurodegeneration / microglia / multiple sclerosis
研究実績の概要

According to the objective of this study, that is, to clarify the cellular interplay between pathogenic CD4+ Th cells, ectopic PRL producing cells and disease-associated microglia in chronic pathogenesis of multiple sclerosis, our current results revealed that microglia played a pivotal role for Eomes+ Th cell-mediated neurodegeneration.
1) Primed microglia under chronic inflammation secreted type I interferon (IFN-I) that induced PRL in antigen-presenting cells and following Eomes expression in Th cells. And interfering activation of microglia attenuates EAE disease.Moreover, blockade of IFN-I signals brings clinical benefits in late EAE.
2) Microglia upregulates surface MHC class II (MHC II) expression. By using GeneChip and single-cell analysis,
we found profoundly gene expression changes during EAE.
3) Intriguingly, we found some proteins as prototypic antigens that stimulate Th cells accumulated in the central nervous system. Such miscellaneous CNS antigens may act as trigger for pathogenesis in late EAE disease
Collectively, our current study highlighted that chronic inflammation in the CNS provoked a functional fluctuation in microglia and immune cells, mutual exchange of which form a previously unappreciated vicious network that leads to neurodegeneration.

現在までの達成度 (区分)
現在までの達成度 (区分)

1: 当初の計画以上に進展している

理由

Most of undergoing experiments and current results are reliable and reasonable according to the objective of this study. Now, the manuscript is preparing.

今後の研究の推進方策

1 To find out what are the possible antigens that are presented by microglia to stimulate Th cells accumulated in the central nervous system. Now, we already screened and selected some possible antigen for test.

2 The distribution of the possible antigens that are presented by microglia in intact and neurodegeneration CNS. We will use cutting-edge Lightsheet Z.1 and SmartLabel system to show the distribution in the whole brain.

3 Clinical benefit of interference of production of the possible antigens that are presented by microglia.
We will use specific inhibitor(s) or antibody to abolish the production or inhibit the binding to helper T cells.

次年度使用額が生じた理由

The amount will be used for 1)animal and stuff;
2) manuscript preparation;
3)moreover, due to Covid-19, conferences include domestic and oversea were cancelled. This year, they are probably to attend.

  • 研究成果

    (1件)

すべて 2021

すべて 雑誌論文 (1件) (うち査読あり 1件、 オープンアクセス 1件)

  • [雑誌論文] Involvement of cytotoxic Eomes-expressing CD4+ T cells in secondary progressive multiple sclerosis2021

    • 著者名/発表者名
      Raveney Ben J. E.、Sato Wakiro、Takewaki Daiki、Zhang Chenyang、Kanazawa Tomomi、Lin Youwei、Okamoto Tomoko、Araki Manabu、Kimura Yukio、Sato Noriko、Sano Terunori、Saito Yuko、Oki Shinji、Yamamura Takashi
    • 雑誌名

      Proceedings of the National Academy of Sciences

      巻: 118 ページ: -

    • DOI

      10.1073/pnas.2021818118

    • 査読あり / オープンアクセス

URL: 

公開日: 2021-12-27  

サービス概要 検索マニュアル よくある質問 お知らせ 利用規程 科研費による研究の帰属

Powered by NII kakenhi